BusinessNew Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment DecisionsBy Nasdaq OMXApr 30, 2018, 1:20 PM UTC
BusinessStudy Published In Managed Care Regarding Prognostic and Cancer-Care Planning Value of Biodesix’s VeriStrat® Proteomic TestBy Nasdaq OMXSep 20, 2017, 3:18 PM UTC
